209 related articles for article (PubMed ID: 3044273)
41. Urinary N-acetyl-beta-D-glucosaminidase activity in leukaemic children during high-dose methotrexate therapy.
Oláh VA; Békési A; Tóth A; Kovács I; Balla G
Haematologia (Budap); 1995; 26(3):151-7. PubMed ID: 7797145
[TBL] [Abstract][Full Text] [Related]
42. Early and quantitative detection of cisplatin-induced nephrotoxicity by measurement of plasma PSP (phenolsulfonphthalein) half-life in rats.
Uozumi J; Ueda T; Koikawa Y; Yasumasu T; Kumazawa J
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):901-4. PubMed ID: 8254999
[TBL] [Abstract][Full Text] [Related]
43. Cisplatin-induced nephrotoxicity and the protective effect of fosfomycin on it as demonstrated by using a crossover study of urinary metabolite levels.
Hayashi M; Numaguchi M; Watabe H; Enomoto H; Yaoi Y
Acta Obstet Gynecol Scand; 1997 Jul; 76(6):590-5. PubMed ID: 9246969
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of renal functions in asphyxiated newborns.
Aggarwal A; Kumar P; Chowdhary G; Majumdar S; Narang A
J Trop Pediatr; 2005 Oct; 51(5):295-9. PubMed ID: 16000344
[TBL] [Abstract][Full Text] [Related]
45. Renal effects of iopentol and iohexol after intravenous injection.
Jakobsen JA; Kolbenstvedt AN; Berg KJ
Acta Radiol; 1991 Jul; 32(4):320-4. PubMed ID: 1863505
[TBL] [Abstract][Full Text] [Related]
46. Urinastatin (Kunitz-type proteinase inhibitor) reducing cisplatin nephrotoxicity.
Umeki S; Tsukiyama K; Okimoto N; Soejima R
Am J Med Sci; 1989 Oct; 298(4):221-6. PubMed ID: 2552802
[TBL] [Abstract][Full Text] [Related]
47. [Antineoplastic therapy and urinary enzymes. Preliminary note on the determination of urinary N-acetyl-beta-D-glucosaminidase in patients treated with cisplatin].
Crovato E; Salvini R
Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2255-60. PubMed ID: 6543318
[TBL] [Abstract][Full Text] [Related]
48. [Acute change in urinary NAG activity following CDDP administration].
Yoshida K; Takahashi T; Nakame Y; Saitoh H; Horiuchi S; Kaneoya F; Negishi T
Hinyokika Kiyo; 1986 Mar; 32(3):369-73. PubMed ID: 3728241
[TBL] [Abstract][Full Text] [Related]
49. Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patients.
Nagai N; Kinoshita M; Ogata H; Tsujino D; Wada Y; Someya K; Ohno T; Masuhara K; Tanaka Y; Kato K; Nagai H; Yokoyama A; Kurita Y
Cancer Chemother Pharmacol; 1996; 39(1-2):131-7. PubMed ID: 8995510
[TBL] [Abstract][Full Text] [Related]
50. [The effect of bismuth subnitrate on cisplatin toxicity].
Chen JT; Kurokawa Y; Nakayama K; Saito K; Sakamoto K; Fukuda K; Hirai Y; Hamada T; Fujimoto I; Yamauchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):815-22. PubMed ID: 3298471
[TBL] [Abstract][Full Text] [Related]
51. [Effect of extracorporeal shock wave lithotripsy on renal function-an experience with the new type piezoelectric lithotripter, Therasonic].
Kageyama Y; Kusuyama H; Lu YW; Nagashima H; Kase H; Araki S; Hobo M; Itoh H; Nakamura K; Katoh M
Hinyokika Kiyo; 1990 Dec; 36(12):1403-7. PubMed ID: 2075877
[TBL] [Abstract][Full Text] [Related]
52. Protective effects of verapamil on cis-platinum and carboplatinum nephrotoxicity in dehydrated and normohydrated rats.
Haragsim L; Zima T
Biochem Int; 1992 Oct; 28(2):273-6. PubMed ID: 1360799
[TBL] [Abstract][Full Text] [Related]
53. [Urinary beta 2-microglobulin as an indicator for impaired excretion of methotrexate].
Amino K; Kawaguchi N; Matsumoto S; Manabe J; Ishii Y; Tabata D; Machida M
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3103-7. PubMed ID: 3056278
[TBL] [Abstract][Full Text] [Related]
54. Urinary enzyme concentrations in the owl monkey (Aotus nancymae).
Weller RE; Málaga CA; Buschbom RL; Ragan HA
J Med Primatol; 1993 Aug; 22(6):340-7. PubMed ID: 8138983
[TBL] [Abstract][Full Text] [Related]
55. Renal tubular dysfunction and urinary zinc excretion in breast cancer patients treated with anthracycline-based combination chemotherapy.
Králícková P; Melichar B; Malír F; Roubal T
J Exp Clin Cancer Res; 2004 Dec; 23(4):579-84. PubMed ID: 15743027
[TBL] [Abstract][Full Text] [Related]
56. [Studies on renal dysfunction after intra-arterial hypertensive chemotherapy (CDDP, PEP) for advanced cancer of the uterine cervix--serum.urinary alpha 1-microglobulin, beta 2-microglobulin and urinary lysozyme, albumin].
Iwanari O; Date Y; Yoshino N; Miyako J; Ryuhkoh K; Moriyama M; Nakayama S; Kitao M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):115-20. PubMed ID: 1690251
[TBL] [Abstract][Full Text] [Related]
57. [Study on urinary beta-glucuronidase and alkaline phosphatase activities as indicators of CDDP renal toxicity].
Takahashi T; Yoshida K; Nakame Y; Saitoh H
Hinyokika Kiyo; 1989 Jan; 35(1):1-6. PubMed ID: 2729012
[TBL] [Abstract][Full Text] [Related]
58. Nephrotoxicity of tobramycin. Value of examining various protein and enzyme markers.
Ylitalo P; Mörsky P; Parviainen MT; Koivula T
Methods Find Exp Clin Pharmacol; 1991 May; 13(4):281-7. PubMed ID: 1875778
[TBL] [Abstract][Full Text] [Related]
59. Changes in urinary excretion of six biochemical parameters in normotensive pregnancy and preeclampsia.
Hayashi M; Ueda Y; Hoshimoto K; Ota Y; Fukasawa I; Sumori K; Kaneko I; Abe S; Uno M; Ohkura T; Inaba N
Am J Kidney Dis; 2002 Feb; 39(2):392-400. PubMed ID: 11840382
[TBL] [Abstract][Full Text] [Related]
60. [Clinical multivariate statistical analysis of nephrotoxicity induced by cisplatin].
Ding DC
Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):64-6. PubMed ID: 1396050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
